Related Experiment Videos
Clinical experience with netilmicin
The Journal of Antimicrobial Chemotherapy
|January 1, 1984
Summary
Netilmicin demonstrates high efficacy in treating bacterial infections, with 90% favorable clinical responses. While generally safe, potential side effects like nephrotoxicity and auditory toxicity were observed in a small percentage of patients.
Area of Science:
- Pharmacology
- Clinical Medicine
- Infectious Diseases
Background:
- Netilmicin is an aminoglycoside antibiotic used for treating bacterial infections.
- Evaluating the efficacy and safety of netilmicin is crucial for its clinical application.
Purpose of the Study:
- To assess the efficacy and safety of netilmicin based on extensive clinical trial data.
- To determine the clinical response rates and pathogen eradication associated with netilmicin treatment.
Main Methods:
- Review of over 150 clinical trials involving 3376 patient treatment courses.
- Analysis of efficacy in 1423 patients with 2273 infections caused by 2322 pathogens.
- Evaluation of safety parameters including nephrotoxicity, auditory toxicity, and vestibular toxicity.
Main Results:
- Favorable clinical responses were observed in 90% of treated infections.
- Eighty-three percent of causative pathogens were eradicated.
- Nephrotoxicity occurred in 1.7% (probable) and 5.2% (possible) of patients.
- Auditory toxicity occurred in 1.6% (probable) and 1.9% (possible) of patients.
- Vestibular toxicity was observed in 0.62% of patients.
Conclusions:
- Extensive clinical trials confirm netilmicin's excellent efficacy in treating bacterial infections.
- Netilmicin exhibits a favorable safety profile, with manageable adverse events.
- The study supports the continued use of netilmicin in clinical practice.